4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide

cytochrome c oxidase subunit II ; Canis lupus familiaris







4 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 25413929 Pharmacokinetics, pharmacodynamics, toxicology and therapeutics of mavacoxib in the dog: a review. 2015 Feb 2
2 25190452 The long-acting COX-2 inhibitor mavacoxib (Trocoxilâ„¢) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro. 2014 Sep 5 3
3 21219337 Population pharmacokinetics of mavacoxib in osteoarthritic dogs. 2011 Feb 2
4 20840390 The pharmacokinetics of mavacoxib, a long-acting COX-2 inhibitor, in young adult laboratory dogs. 2010 Oct 1